Posted inStock
HIMS Stock Jumps 11% to $26 Today as Novo Nordisk Deal Clears Legal Risk, Barclays Sets $29 Target
Hims & Hers Health (NYSE: HIMS) jumped sharply in Wednesday trading, with the stock climbing nearly 11% to $26.19 today after a landmark partnership with Novo Nordisk removed a key…







